Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: ISRCTN64428072. We help you review the study, but cannot decide medical eligibility.
Not recruitingISRCTN64428072
A study on the safety, tolerability, and effects of GM-2505
A short description of this study’s research objective has not yet been verified.
Research studyNetherlandsDepression
Understand this study
We have not yet verified a detailed participation summary for this study.
- Listed locations
- Netherlands
- Compensation
- Payment and expense reimbursement have not been verified.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Not recruiting
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Gilgamesh Pharmaceuticals
- Sponsor type
- Unknown or unclear
- Study type
- Other
- Intervention type
- Other / unclear
- Study phase
- Not clearly listed
- Locations
- Netherlands
- Age range
- Not clearly listed
- Official registry ID
- ISRCTN64428072
- Official title
- A study on the safety, tolerability, and effects of GM-2505
Recruitment & locations
Not recruitingNetherlands
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Gilgamesh Pharmaceuticals.
Is this study still recruiting?
The registry lists this study as not recruiting.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
Not recruitingISRCTN68246470
(Cost)effectiveness of a cognitive group prevention module for recurrent depression
This study is not recruiting. It focuses on depression and currently lists study information in the Netherlands.
Not recruitingISRCTN23246262
A comparison of the efficacy and the safety of venlafaxine versus nortriptyline in the treatment of depressed elderly inpatients
This study is not recruiting in the Netherlands. It focuses on Depression.
Not recruitingISRCTN30877831
Addition of eicosapentaenoic acid to maintenance anti-depressant therapy in diabetes people with major depressive disorder: a study
This study is not recruiting in the Netherlands. It focuses on depression.